Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BioVentrix Inc.

www.bioventrix.com

Latest From BioVentrix Inc.

Start-Up Spotlight: BioVentrix Expects Revivent TC Heart Failure Device To Succeed Where Others Failed

Two-year data from a European trial showed BioVentrix’s Revivent TC system significantly reduces left-ventricular volume and improves left-ventricular function in patients with heart failure following a myocardial infarction. The company expects to complete a US pivotal trial of the device in 2021 and launch the device in the US with funding from a planned initial public offering.

Start-up Spotlight Innovation

BioVentrix Advances Its Revivent-TC Ventricular Enhancement Technology For Heart Failure

BioVentrix Inc. has its sights set on US market approval for its hybrid transthoracic-endovascular Revivent-TC system, a unique device that enables a minimally invasive approach to treating patients who develop ischemic heart failure following a heart attack.

Medical Device North America

Medtech VCs Show Steady Hand With Dollars Invested in 2013

Despite contraction in the number of funds and VC firms investing in life sciences, 2013 was a strong year for private investing in medtech, with private investors putting $2.54 million into 129 medical device deals, according to Informa’s Strategic Transactions. Looking at where investors placed their money revealed some emerging trends.

Medical Device Deals

Medtech Execs On The Move, October 2013

Recent executive-level company changes and promotions in the medical device and diagnostics industries.

Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • CHF Technologies Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • BioVentrix Inc.
  • Senior Management
  • Ken Miller, Pres. & CEO
    William Abbott, CFO
    Lon S Annest, MD, CMO
    Kevin Van Bladel, VP, R&D
    David Schickling, VP, Sales & Mktg.
    Serjan D Nikolic, PhD, VP, Therapy Dev.
  • Contact Info
  • BioVentrix Inc.
    Phone: (925) 830-1000
    12647 Alcosta Blvd.
    Ste. 400
    San Ramon, CA 94583
    USA
UsernamePublicRestriction

Register